EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD)

被引:65
作者
Grandy, Susan [2 ]
Fox, Kathleen M. [1 ]
机构
[1] Strateg Healthcare Solut LLC, Monkton, MD USA
[2] AstraZeneca Pharmaceut LP, Wilmington, DE USA
关键词
D O I
10.1186/1477-7525-6-18
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The EQ-5D was used to compare burden experienced by respondents with diabetes and those at risk for diabetes. Methods: A survey including the EQ-5D was mailed to individuals with self-reported diabetes, as well as those without diabetes but with the following risk factors (RFs): (1) abdominal obesity, (2) body mass index = 28 kg/m(2), (3) dyslipidemia, (4) hypertension, and (5) cardiovascular disease. Non-diabetes respondents were combined into 0-2 RFs and 3-5 RFs. Mean EQ-5D scores were compared across groups using analysis of variance. Multivariable linear regression modeling identified factors affecting respondents' EQ-5D scores. Results: Complete responses were available from > 75% of each cohort. Mean EQ-5D index scores were significantly lower for respondents with type 2 diabetes and 3-5 RFs (0.778 and 0.792, respectively) than for those with 0-2 RFs (0.870, p < 0.001 for each); score for respondents with type 2 diabetes was also significantly lower than for those with 3-5 RFs (p < 0.001). Similar patterns were seen for visual analog scale (VAS). For both VAS and index scores, after adjusting for other characteristics, respondents reported decreasing EQ-5D scores as status moved from low to high risk (-6.49 for VAS score and -0.045 for index score) to a diagnosis of type 2 diabetes (-9.75 for VAS score and -0.054 for index score; p < 0.001 vs. 0 -2 RFs for all). Conclusion: High-risk and type 2 diabetes groups had similar EQ-5D scores, and both were substantially lower than in low-risk respondents.
引用
收藏
页数:7
相关论文
共 29 条
  • [1] *AM DIAB ASS, COMP DIAB US
  • [2] A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM
    Anderson, RM
    Fitzgerald, JT
    Wisdom, K
    Davis, WK
    Hiss, RG
    [J]. DIABETES CARE, 1997, 20 (03) : 299 - 305
  • [3] [Anonymous], 2007, DIABETES CARE, DOI DOI 10.2337/DC07-S004
  • [4] [Anonymous], 2005, National diabetes fact sheet
  • [5] The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys
    Bays, H. E.
    Chapman, R. H.
    Grandy, S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (05) : 737 - 747
  • [6] CAVRINI G, 2004, PROPOSAL MODELING EQ
  • [7] Patient-assessed health outcome measures for diabetes: a structured review
    Garratt, AM
    Schmidt, L
    Fitzpatrick, R
    [J]. DIABETIC MEDICINE, 2002, 19 (01) : 1 - 11
  • [8] Quality of life in NIDDM patients assessed with the SF-20 questionnaire
    Hänninen, J
    Takala, J
    Keinänen-Kiukaanniemi, S
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 42 (01) : 17 - 27
  • [9] Hart HE, 2007, INDIAN J MED RES, V125, P203
  • [10] Hurst NP, 1997, BRIT J RHEUMATOL, V36, P551